Cargando…
In Silico Screening of a Bile Acid Micelle Disruption Peptide for Oral Consumptions from Edible Peptide Database
Recently, many bioactive peptides have been identified using bioinformatics tools. Previously, our group developed a method to screen dual-functional peptides that have direct intestinal delivery with porous silica gel and bile acid micelle disruption. However, newly designed peptides were not found...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536064/ https://www.ncbi.nlm.nih.gov/pubmed/34681544 http://dx.doi.org/10.3390/foods10102496 |
_version_ | 1784587934422269952 |
---|---|
author | Imai, Kento Takeuchi, Yuri Shimizu, Kazunori Honda, Hiroyuki |
author_facet | Imai, Kento Takeuchi, Yuri Shimizu, Kazunori Honda, Hiroyuki |
author_sort | Imai, Kento |
collection | PubMed |
description | Recently, many bioactive peptides have been identified using bioinformatics tools. Previously, our group developed a method to screen dual-functional peptides that have direct intestinal delivery with porous silica gel and bile acid micelle disruption. However, newly designed peptides were not found in any storage protein. Therefore, in this study, in silico screening was performed using a 350,000 edible peptide library consisting of 4- to 7-mer independent peptides. As an initial screening, all edible peptides were applied to the random forest model to select predicted positive peptides. For a second screening, the peptides were assessed for the possibility of intestinal delivery using a 3D color map. From this approach, three novel dual-functional peptides, VYVFDE, WEFIDF, and VEEFYC were identified, and all of them were derived from storage proteins (legumin, myosin, and 11S globulin). In particular, VEEFYCS, in which a serine residue (S) is added to VEEFYC, was assumed to be released by thermolysin from the 11S-globulin derived from Ginkgo biloba by LC-MS/MS analysis. VEEFYCS was found to have suitable direct intestinal delivery and bile acid micelle disruption activity. |
format | Online Article Text |
id | pubmed-8536064 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85360642021-10-23 In Silico Screening of a Bile Acid Micelle Disruption Peptide for Oral Consumptions from Edible Peptide Database Imai, Kento Takeuchi, Yuri Shimizu, Kazunori Honda, Hiroyuki Foods Article Recently, many bioactive peptides have been identified using bioinformatics tools. Previously, our group developed a method to screen dual-functional peptides that have direct intestinal delivery with porous silica gel and bile acid micelle disruption. However, newly designed peptides were not found in any storage protein. Therefore, in this study, in silico screening was performed using a 350,000 edible peptide library consisting of 4- to 7-mer independent peptides. As an initial screening, all edible peptides were applied to the random forest model to select predicted positive peptides. For a second screening, the peptides were assessed for the possibility of intestinal delivery using a 3D color map. From this approach, three novel dual-functional peptides, VYVFDE, WEFIDF, and VEEFYC were identified, and all of them were derived from storage proteins (legumin, myosin, and 11S globulin). In particular, VEEFYCS, in which a serine residue (S) is added to VEEFYC, was assumed to be released by thermolysin from the 11S-globulin derived from Ginkgo biloba by LC-MS/MS analysis. VEEFYCS was found to have suitable direct intestinal delivery and bile acid micelle disruption activity. MDPI 2021-10-18 /pmc/articles/PMC8536064/ /pubmed/34681544 http://dx.doi.org/10.3390/foods10102496 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Imai, Kento Takeuchi, Yuri Shimizu, Kazunori Honda, Hiroyuki In Silico Screening of a Bile Acid Micelle Disruption Peptide for Oral Consumptions from Edible Peptide Database |
title | In Silico Screening of a Bile Acid Micelle Disruption Peptide for Oral Consumptions from Edible Peptide Database |
title_full | In Silico Screening of a Bile Acid Micelle Disruption Peptide for Oral Consumptions from Edible Peptide Database |
title_fullStr | In Silico Screening of a Bile Acid Micelle Disruption Peptide for Oral Consumptions from Edible Peptide Database |
title_full_unstemmed | In Silico Screening of a Bile Acid Micelle Disruption Peptide for Oral Consumptions from Edible Peptide Database |
title_short | In Silico Screening of a Bile Acid Micelle Disruption Peptide for Oral Consumptions from Edible Peptide Database |
title_sort | in silico screening of a bile acid micelle disruption peptide for oral consumptions from edible peptide database |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536064/ https://www.ncbi.nlm.nih.gov/pubmed/34681544 http://dx.doi.org/10.3390/foods10102496 |
work_keys_str_mv | AT imaikento insilicoscreeningofabileacidmicelledisruptionpeptidefororalconsumptionsfromediblepeptidedatabase AT takeuchiyuri insilicoscreeningofabileacidmicelledisruptionpeptidefororalconsumptionsfromediblepeptidedatabase AT shimizukazunori insilicoscreeningofabileacidmicelledisruptionpeptidefororalconsumptionsfromediblepeptidedatabase AT hondahiroyuki insilicoscreeningofabileacidmicelledisruptionpeptidefororalconsumptionsfromediblepeptidedatabase |